Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a chinese population

American Journal of Epidemiology

Volumn 173, Issue 8, 2011, Pages 915-922

  Chen, Hongyan ^a   Chen, Yuanyuan ^a   Zhao, Yao ^b   Fan, Weiwei ^a   Zhou, Keke ^b   Liu, Yanhong ^c   Zhou, Liangfu ^b   Mao, Ying ^b   Wei, Qingyi ^c   Xu, Jianfeng ^d   Lu, Daru ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Asian continental ancestry group; association; genetic variation; genetics; genome wide association study; glioma; polymorphism, single nucleotide

Indexed keywords

ANCESTRY; CHROMOSOME; GENETIC VARIATION; GENOME; GENOTYPE; HEALTH RISK; MOLECULAR ANALYSIS; POLYMORPHISM; RISK FACTOR; TUMOR;

ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CHINESE; CHROMOSOME 11Q; CHROMOSOME 20Q; CHROMOSOME 5P; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; GLIOBLASTOMA; GLIOMA; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CHROMOSOMES, HUMAN; DNA HELICASES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIOBLASTOMA; GLIOMA; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TELOMERASE;

CHINA; EUROPE;

EID: 79953875872     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq457     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-249.
2. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109(1):93-108. (Pubitemid 40287792)
3. National Bureau of Statistics of China. China's Health Statistics Yearbook 2009 [in Chinese]. Peking, China: Peking Union Medical College Press 2009: 254. ( http://www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjnj/ year2009/t-9.htm). (Accessed May 24,2010).
4. Little MP, de Vathaire F, Shamsaldin A, et al. Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int J Cancer. 1998;78(3):269-275. (Pubitemid 28445359)
5. Xue QC, Pu PY, Yang YS, et al. A survey of 790 cases of astrocytoma. Clin Neurol Neurosurg. 1990;92(1):27-33.
6. Bondy ML, Scheurer ME, Malmer B, et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer. 2008;113(suppl 7):1953-1968.
7. Bondy ML, Wang LE, El-Zein R, et al. Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst. 2001;93(20): 1553-1557.
8. Wang LE, Bondy ML, Shen H, et al. Polymorphisms of DNA repair genes and risk of glioma. Cancer Res. 2004;64(16): 5560-5563. (Pubitemid 39095549)
9. McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, et al. Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev. 2009; 18(4):1118-1126.
10. Kiuru A, Lindholm C, Heinävaara S, et al. XRCC1 and XRCC3 variants and risk of glioma and meningioma. J Neurooncol. 2008;88(2):135-142.
11. Liu Y, Scheurer ME, El-Zein R, et al. Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev. 2009;18(1): 204-214.
12. Felini MJ, Olshan AF, Schroeder JC, et al. DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas. Neuroepidemiology. 2007;29(1-2):55-58. (Pubitemid 350191418)
13. Chen P, Wiencke J, Aldape K, et al. Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev. 2000;9(8):843-847. (Pubitemid 30660059)
14. Wrensch M, Kelsey KT, Liu M, et al. ERCC1 and ERCC2 polymorphisms and adult glioma. Neuro Oncol. 2005;7(4): 495-507. (Pubitemid 41555621)
15. Bhowmick DA, Zhuang Z, Wait SD, et al. A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res. 2004;64(4): 1220-1223. (Pubitemid 38235584)
16. Costa BM, Ferreira P, Costa S, et al. Association between functional EGF\+61 polymorphism and glioma risk. Clin Cancer Res. 2007;13(9):2621-2626. (Pubitemid 46788028)
17. Schwartzbaum J, Ahlbom A, Malmer B, et al. Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res. 2005;65(14): 6459-6465. (Pubitemid 40994435)
18. Amirian E, Liu Y, Scheurer ME, et al. Genetic variants in inflammation pathway genes and asthma in glioma susceptibility. Neuro Oncol. 2010;12(5):444-452.
19. Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41(8):899-904.
20. Wrensch M, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009;41(8): 905-908.
21. Liu Y, Zhou K, Zhang H, et al. Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat. 2008;29(3):381-389. (Pubitemid 351364940)
22. Liu Y, Zhang H, Zhou K, et al. Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. Carcinogenesis. 2007;28(9):1906-1913. (Pubitemid 47500602)
23. Zhou K, Liu Y, Zhang H, et al. XRCC3 haplotypes and risk of gliomas in a Chinese population: a hospital-based case-control study. Int J Cancer. 2009;124(12):2948-2953.
24. Rafnar T, Sulem P, Stacey SN, et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet. 2009;41(2):221-227.
25. Jurinke C, van den Boom D, Cantor CR, et al. Automated genotyping using the DNA MassArray technology. Methods Mol Biol. 2002;187:179-192.
26. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716-23.
27. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263-265. (Pubitemid 40202029)
28. Ding H, Schertzer M, Wu X, et al. Regulation of murine telomere length by Rtel: an essential gene encoding a helicase-like protein. Cell. 2004;117(7):873-886. (Pubitemid 38798854)
29. Barber LJ, Youds JL, Ward JD, et al. RTEL1 maintains geno-mic stability by suppressing homologous recombination. Cell. 2008;135(2):261-271.
30. Wager M, Menei P, Guilhot J, et al. Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study. Br J Cancer. 2008;98(11):1830-1838. (Pubitemid 351748843)
31. Wang L, Wei Q, Wang LE, et al. Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. J Clin Oncol. 2006;24(10):1627-1632. (Pubitemid 46638787)
32. Stacey SN, Sulem P, Masson G, et al. New common variants affecting susceptibility to basal cell carcinoma. Nat Genet. 2009;41(8):909-914.
33. Zienolddiny S, Skaug V, Landvik NE, et al. The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis. 2009;30(8):1368-1371.
34. Rutherford S, Cai G, Lopez-Alvarenga JC, et al. A chromosome 11q quantitative-trait locus influences change of blood-pressure measurements over time in Mexican Americans of the San Antonio Family Heart Study. Am J Hum Genet. 2007;81(4):744-755. (Pubitemid 47596542)
35. Guo C, White PS, Weiss MJ, et al. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene. 1999;18(35):4948-4957. (Pubitemid 29425301)